F

Fennec Pharmaceuticals
D

FENC

11.323
USD
-0.52
(-4.39%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-94
حجم السوق
397,065,441
أصول ذات صلة
المزيد
المقالات
المزيد

العنوان: Fennec Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.